- Filed
- Mar 31, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 24, 2025 | 3.01M sh |
| Shares Diluted restated | FY 2024 · Dec 31, 2023 | 569K sh |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$125.18M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $17.95M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $100.03M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $118.25M |
| Current Assets | FY 2024 · Dec 31, 2023 | $140.12M |
| Total Assets | FY 2024 · Dec 31, 2023 | $214.4M |
| Eps Diluted restated | FY 2024 · Dec 31, 2023 | −$408.60 |
| Eps Basic restated | FY 2024 · Dec 31, 2023 | −$408.60 |
| Sga Expense restated | FY 2024 · Dec 31, 2023 | $92.76M |
| Rd Expense | FY 2024 · Dec 31, 2023 | $54.03M |
| Net Income | FY 2024 · Dec 31, 2023 | −$232.49M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$215.25M |
| Cost Of Revenue | FY 2024 · Dec 31, 2023 | $26.55M |
| Revenue | FY 2024 · Dec 31, 2023 | $36.12M |
| Stockholders Equity restated | FY 2024 · Dec 31, 2022 | $249.4M |